Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

"…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …"

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. حسب Denis Mustafov (19137870)

Analysis of Significantly Different Bacteria. حسب Xu Jia (187142)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. حسب Denis Mustafov (19137870)

Analysis of Significantly Different ARGs and Resistance Mechanisms. حسب Xu Jia (187142)

Everolimus decreased CD89 deposits in α1^KICD89^Tg mice. حسب Alexandra Cambier (22307216)

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. حسب Hyung Suk Yang (20442438)

الموضوعات:

Everolimus decreased IgA1 deposits in glomeruli of α1^KICD89^Tg mice. حسب Alexandra Cambier (22307216)

Everolimus decreased mesangial TfR1 expression in α1^KICD89^Tg mice. حسب Alexandra Cambier (22307216)

Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs. حسب Pingling Kwok (14896191)

الموضوعات:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. حسب Francesca Catto (21253435)

"…Additionally, the plots on the right side display the average plaque count across the cohorts. …"

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. حسب Richard Junior Zapata Dongo (17912565)

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. حسب Thomas Hanslmeier (19949694)

الموضوعات:

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). حسب Thomas Hanslmeier (19949694)

الموضوعات:

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... حسب Thomas Hanslmeier (19949694)

الموضوعات:

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. حسب Thomas Hanslmeier (19949694)

الموضوعات:

UTI diagnoses by sex and physician specialty (2013–2019). حسب Thomas Hanslmeier (19949694)

الموضوعات: